CDC PHIL image[/caption]
MedicalResearch.com: What is the background for this study?
Response: This report reviewed three measures of tooth loss among adults over 50 years old with selected chronic conditions. The report analyzed data from the 2011–2016 cycles of the National Health and Nutrition Examination Survey (NHANES) to compare the rates of total tooth loss, severe tooth loss (less than 8 teeth), and lacking functional dentition (less than 20 teeth) among people with and without selected chronic conditions.
Dr. Morichau-Beauchant[/caption]
Dr Tristan Morichau-Beauchant, MD.
Intensive Care Unit
Centre Cardiologique du Nord
Saint-Denis, France
MedicalResearch.com: What is the background for this study?
Response: During the spread of the COVID-19 epidemic in France, early reports on severe patients stated a highly increased inflammatory response associated with procoagulant changes in coagulation pathways and high D-Dimer levels. Preliminary reports from the intensive care community signaled frequent events of deep vein thrombosis (DVT) among this population. We decided to perform prospectively a venous ultrasonogram of the inferior limbs for all patients with severe COVID-19 pneumonia at admission in our ICU. All patients had acute respiratory distress syndrome according to the Berlin definition an required mechanical ventilation. Considering the high prevalence of venous thrombosis at admission we repeated a venous ultrasonography after 48 hours if the first exam was normal. All patients received standard anticoagulant prophylaxis since hospital admission.
It is important to remember that the FDA does not regulate dietary supplements. This means that, unlike medications and drugs, supplements do not have to meet any strict standards....
Dr. Jonas[/caption]
Brian A. Jonas, M.D., Ph.D.
UC Davis Health System
MedicalResearch.com: What is the background for this study?
At this year’s American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) virtual meetings, we presented data on the rapidity and likelihood of response to venetoclax treatments, and its associated characteristics, in older patients with newly diagnosed acute myeloid leukemia (AML).
We evaluated data from two clinical trials of venetoclax in combination with azacitidine, or decitabine (M14-358), or low-dose cytarabine (LDAC) (M14-387) in this patient population.
Dr. Soumya Sen[/caption]
Soumya Sen PhD
McKnight Presidential Fellow
Mary & Jim Lawrence Fellow of Carlson School
Director of Research, MIS Research Center
Associate Professor, Information & Decision Sciences
Carlson School of Management
University of Minnesota, Minneapolis, MN
MedicalResearch.com: What is the background for this study?
Response: As the Covid-19 pandemic unfolded across the United States, one of the greatest barriers to understanding the extent of the problem was the lack of reliable and consistent data. Some of the metrics being reported, such as case count and death, are insufficient for hospital capacity planning. Case count is a conservative estimate of the actual number of infected individuals in the absence of community-wide serologic testing, while death count is a lagging metric and insufficient for proactive hospital capacity planning.
A more valuable metric for assessing the effects of public health interventions on the health care infrastructure is hospitalizations. Therefore, the Medical Industry Leadership Institute (MILI) and the Management Information Systems Research Center (MISRC) at the Carlson School of Management launched the COVID-19 hospitalization tracking project in March to consistently track and report daily hospitalizations from all reporting states. Tracking daily hospitalization data is a major step forward in quantifying the current impact on local hospital systems, modeling and forecasting future utilization needs, and tracking the rate of change in the disease severity. It is also useful for understanding the role of health policy interventions in slowing or reducing the impact of the pandemic.
Dr. Boffa[/caption]
Daniel J. Boffa, MD
Associate Professor of Thoracic Surgery
Yale School of Medicine
MedicalResearch.com: What is the background for this study?
Response: The study examined networks that formed around hospitals that had been previously ranked in the top-50 by US News and World Report. These top-ranked hospitals have shared their brand with hospitals in their network, which leads some people to believe that the care is the same at top-ranked hospitals and their affiliate hospitals. We wanted to determine if outcomes after complex surgical procedures were truly the same at affiliate hospitals and top-ranked hospitals.
Dr. Jian Feng Zhou[/caption]
Jianfeng Zhou MD, PhD
Department of Hematology, Tongji Hospital
Tongji Medical College
Huazhong University of Science and Technolog
Wuhan, Hubei, China
MedicalResearch.com: What is the background for this study?
Response: There is accumulating evidence on the key pathophysiological role of cytokines during the severe stage of COVID-19. In the context of lack of vaccine and specific antiviral agents, testing of immunomodulatory agents to reduce excessive or uncontrolled inflammation before it results in irreversible multi-organ dysfunction infection has received increasing research attention. Although several important papers have proposed JAK inhibitors as potential therapeutic targets, the role of JAK inhibitors on COVID-19 patients needs to be clarified quickly, especially in severe COVID-19 patients.
Women remain more at risk of liver disease resulting from alcohol use, although heavy users of both sexes develop fatty liver over time...
Dr. Pesch[/caption]
Megan H. Pesch, MD, MS, FAAP
Assistant Professor
C.S. Mott Children’s Hospital
University of Michigan
MedicalResearch.com: What is the background for this study?
Response: Picky eating is common among children and is often both concerning to parents. Healthcare providers may reassure parents that their child will “outgrow” picky eating, however there have been few longitudinal studies examining the trajectories of picky eating in children, as well as associated trends in their growth.
In our study we examined the trajectories of picky eating in US children over a 5 year period. We also examined how these picky eating trends were associated with child characteristics, weight status and mother’s feeding behaviors.
A recent study from Services for the UnderServed found that between 37 and 56 percent of patients transitioning from residential treatment facilities to their homes and communities relapsed within a year of leaving the program....
Dr. Giugliano[/caption]
Robert P. Giugliano, MD, SM
Senior Investigator, TIMI Study Group
Cardiovascular Medicine
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School Boston, MA
MedicalResearch.com: What is the background for this study?
Response: Some prior studies had suggested that lipid lowering therapies were associated with impaired cognition. We sought to explore this question in a prospectively designed substudy of the large FOURIER randomized, double-blind clinical trial utilizing patient self-surveys administered the end of the study to determine whether patients themselves noticed any changes in cognition over the duration of the trial.
The survey tool was a shortened version of the Everyday Cognition Questionnaire (see attached) that asks patients 23 questions that assess memory and executive function (including subdomains of planning, organization, and divided attention). The questions are in the format of "Compared to the beginning of the study, has there been any change in .....", and are graded as 1=better/no change, 2=questionable/occasionally worse, 3=consistently a little worse, 4=consistently much worse.
Nembro Italy: Wikipedia-Image[/caption]
Marco Piccininni
Research Associate, CONVERGE
Universitätsmedizin
Institute of Public Health
Berlin, Germany
MedicalResearch.com: What is the background for this study?
Response: The Lombardy region of northern Italy was severely hit by the covid-19 pandemic. However, despite the very high number of confirmed covid-19 deaths in this region, some local investigations suggested that there was a mismatch between the confirmed covid-19 death count and the increase in all-cause deaths.
In our study, we decided to further investigate this aspect in the city of Nembro (province of Bergamo), which was one of the first cities to report covid-19 cases, and one of the cities most affected by the pandemic.
Dr. Hennekens[/caption]
Charles H. Hennekens, MD, DrPH
Sir Richard Doll Professor
Senior Academic Advisor
FAU, Boca Raton, FL
MedicalResearch.com: What is the background for this study?
Response: Blacks and other disadvantaged minorities in the United States have markedly reduced life expectancies compared with their white counterparts. As is the case with most fatal diseases, coronavirus disease (COVID-19) is already taking a disproportionate toll on blacks and other disadvantaged minorities.
Dr. Filbey[/caption]
Francesca Filbey, PhD
Associate Provost and Professor of Cognition and Neuroscience
Bert Moore Chair
The University of Texas at Dallas
MedicalResearch.com: What is the background for this study?
Response: Studies have reported differences in how males and females respond to cannabis and how they develop problems related to cannabis use. We sought to determine whether craving may underlie this difference in male and female cannabis users.
Dr. Zhu[/caption]
Yanmin Zhu, M.S., Ph.D.
Postdoctoral Research Fellow
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital and Harvard Medical School
MedicalResearch.com: What is the background for this study?
Response: Animal studies and case reports suggest a potential teratogenic effect associated with the use of high doses of fluconazole during pregnancy. The malformations reported in case reports have a distinct phenotype, including femoral bowing, thin ribs, cleft palate, and abnormal craniofacial ossification.
A few controlled studies have examined the risk of congenital malformations associated with the use of fluconazole during the first trimester, but findings are inconsistent.
Dr. Yaghi[/caption]
Shadi Yaghi, MD
Assistant Professor
Department of Neurology at NYU Grossman School of Medicine
Director, Clinical Vascular Neurology Research, NYU Langone Health
Director, Vascular Neurology, NYU Langone Hospital-Brooklyn
MedicalResearch.com: What is the background for this study?
Response: Our aim was to determine the characteristics of imaging proven ischemic stroke in the setting of COVID-19 infection and compare them to those of ischemic stroke but without COVID-19 infection.
Dr. Brooks[/caption]
Dr. Kelly Brooks PhD
Research Officer
QIMR Berghofer Medical Research Institute
MedicalResearch.com: What is the background for this study?
[caption id="attachment_54258" align="alignleft" width="200"]
An example of uveal melanoma
Dr. Palm[/caption]
Dr. Melanie D. Palm, MD, MBA
Board-certified dermatologist and cosmetic surgeon
San Diego, CA
Clinical investigator in the Restylane Kysse phase 3 Galaderma trial
Dr. Palm discusses the recent announcement that the FDA has approved Restylane® Kysse for lip augmentation and the correction of upper perioral rhytids (wrinkles) in adults over the age of 21.
MedicalResearch.com: What is the background for this announcement?
Dr. Myers[/caption]
Sara P. Myers, M.D., Ph.D.
University of Pittsburgh School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Compared to other fields, medicine, and especially academic surgery and its subspecialties, trail with respect to gender diversity. Considering that these fields were traditionally male-dominated, two issues that may present ongoing challenges to the retention and promotion of women are pro-male bias and negative stereotypes about women. Training specific to pursuing a surgical career begins in residency, so it is important to understand how these issues affect motivation and achievement during this formative period.
In our study we first evaluated the association between pro-male bias and research-related career engagement using a survey methodology, and then looked at whether evoking negative stereotypes about women was associated with reduced performance on a simulated technical skill assessment called the Fundamentals of Laparoscopic Surgery (FLS) assessment.
Dr. Ascierto[/caption]
Paolo A. Ascierto, MD
Melanoma. Cancer Immunotherapy and Development Therapeutics Unit
Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale"
Napoli - Italy
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: As we know, in Covid-19 pneumonia, especially in its complication “acute respiratory distress syndrome (ARDS)”, a key role is played by the immune system. We know that when we treat a tumor with immunotherapy, it could give side effects because the stimulated immune system produces a series of substances to destroy the tumor. Sometimes, the immune system can also give side effects related to a hypersecretion of some cytokines, such as IL 6, the target of tocilizumab. This condition is called cytokine storm, or better, cytokine release syndrome (CRS).Oncologists use tocilizumab in the management of CRS that can occur following the use of bispecific antibodies, or recently, the use of CAR-T cell therapy, where such drug is approved for CRS treatment.
Dr. Galsky[/caption]
Matthew Galsky, MD
Icahn School of Medicine at Mount Sinai
New York, NY
MedicalResearch.com: What is the background for this study?
Response: Standard first-line treatment for metastatic urothelial (bladder) cancer has been platinum-based chemotherapy for decades. In 2016, atezolizumab, an immunotherapy that inhibits PD-L1, received accelerated approval by the FDA for the treatment of metastatic urothelial cancer for patients progressing despite prior platinum-based chemotherapy and this was followed by approvals for 4 additional PD-1 or PD-L1 inhibitors in this setting over the next couple years. With this first new drug class approved, representing the first new drugs approved for metastatic urothelial cancer for decades, logical question arose
(a) should we combine these drugs with platinum-based chemotherapy in the first-line metastatic treatment setting and
(b) is there a role to replace first-line chemotherapy with atezolizumab monotherapy. The IMvigor 130 trial was designed to address these questions.
The trial enrolled 1213 patients who were randomized to treatment with (a) atezolizumab plus platinum-based chemotherapy, (b) placebo + platinum-based chemotherapy, or (c) atezolizumab monotherapy. The trial employed a hierarchical analysis plan such that comparisons between arms for certain endpoints could only be formally tested if other the preceding comparisons demonstrated a significant improvement.
Dr. Berdeja[/caption]
Dr. Jesus G. Berdeja, MD
Director of Myeloma Research
Sarah Cannon
Nashville, TN
MedicalResearch.com: What is the background for this study?
Response: Despite many advances in the treatment of multiple myeloma in recent years, the majority of patients will progress through all available therapies and ultimately succumb to their disease. Thus there is still a high unmet medical need.
The Phase 1b/2 CARTITUDE-1 study evaluates the safety and efficacy of JNJ-4528, an investigational BCMA-directed CAR-T therapy, in the treatment of patients with relapsed or refractory multiple myeloma. Participants in this study have already tried approved therapies, and had received a median of five prior treatment regimens and their median overall survival is less than 12 months.
Dr. Cavanaugh[/caption]
Alyson Cavanaugh, PT, PhD
Joint Doctoral Program in Epidemiology
University of California, San Diego/ San Diego State University
MedicalResearch.com: What is the background for this study?
Response: More than 700,000 total knee replacements are performed annually in the United States, but there is a racial disparity in outcomes after the surgery. If the knee replacement procedure is considered a highly effective treatment, why don't black women present with the same outcomes as whites?
Physical function when going into surgery has a large impact on the potential functional outcomes after surgery. Our hypothesis was that black women were presenting to surgery with poorer physical function, which was contributing to poorer functional outcomes after surgery.
Dr. Van der Pol[/caption]
Barbara Van Der Pol, PhD, MPH
President, American STD Association
President-Elect, International Society fo STD Research
Professor of Medicine & Public Health
Director, STD Diagnostics Lab
Director, UAB STD Clinical Research Organization
University of Alabama at Birmingham
Birmingham, AL 35294
MedicalResearch.com: What is the background for this study?
Response: For many decades, public health programs focused on control and prevention of sexually transmitted infections (STI) have relied on lab based tests that required a 1-day to 1-week wait for test results. Efforts to shorten the duration of infection lead to treating at the time of the clinic visit based on the association between certain clinical signs or symptoms and the likelihood of infection.
Unfortunately, more than ½ of infected persons do not have signs or symptoms so they receive no treatment until test results are available. Thus, a test that could be performed at the clinical site with a limited wait time would improve the accuracy of treatment and shorten the duration of infection. Such a strategy will hopefully reduce the number of return clinic visits, the possibility of transmission, and the potential for consequences of untreated infection such as infertility.
Dr. Chambers[/caption]
James D. Chambers, PhD, MPharm, MSc
Associate Professor of Medicine
Tufts Medical Center Institute for Clinical Research and Health Policy Studies
MedicalResearch.com: What is the background for this study?
Response: We know that biosimilars have not had the same uptake in the US as they have had elsewhere. We know that this is in part due to reference product manufacturer tactics to delay biosimilar market entry and patent disputes.
In this study we examined whether lack of preferred coverage by commercial health insurers may also play a role.
Dr. Martin[/caption]
Sara Martin, MD, MSc
Santa Rosa Family Medicine Residency Program
Santa Rosa, California
MedicalResearch.com: What is the background for this study?
Response: To improve access to comprehensive primary care, we need to understand how much is being spent on primary care. Until recently, the United States lacked any data-based estimate of primary care expenditure. This study utilizes Medical Expenditure Panel Survey (MEPS)data from 2002 – 2016 to estimate the percentage of healthcare expenditures that was spent on primary care.
Most discussions around health care expenditure in the U.S. focus on the fact that we spend more than any other country and do not have the corresponding outcomes to match that investment. This paper focuses the conversation around the distribution of the expenditure.
Dr. Tandon[/caption]
Pooja S. Tandon, MD, MPH
Center for Child Health, Behavior and Development
Seattle Children's Research Institute
MedicalResearch.com: What is the background for this study?
Response: Cell phone use is common among middle and high school students, yet we do not have an understanding of school cell phone policies and practices in the U.S. We conducted a survey of public schools serving grades 6-12. The survey sent to over 1,100 school principals, representing a national sample of schools across the U.S., asked questions about the presence of a cell phone policy for students and staff and restrictions on phone use. Additional questions addressed consequences of policy violation, the use of cell phones for curricular activities and principals’ attitudes toward cell phone policies.